The effect of Nasturtium officinale extract on biomarkers in asthma patients
Phase 3
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT20201215049726N1
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Both sexes
age 18-65 years
asthma diagnosis based on the Global Initiative for Asthma (GINA)
asthma symptoms not fully controlled based on ACT (Asthma Control Test) score from 5 to24
no severe asthma exacerbation in the last four weeks
Complete conscious satisfaction
Exclusion Criteria
smoking history
pregnant women
taking any preparation containing NOE
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ACT score. Timepoint: 0-28 days. Method of measurement: Asthma Control Test questionnaire.
- Secondary Outcome Measures
Name Time Method Protein carbonyl. Timepoint: 0-28. Method of measurement: Spectrophotometry.;Total thiol content. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.;Protein sulfhydryl. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.;Malondialdehyde. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.;The ferric reducing antioxidant power. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.;Glutathione peroxidase enzyme. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.;Superoxide dismutase enzyme. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.;Catalase enzyme. Timepoint: 0-28 days. Method of measurement: Spectrophotometry.